Advertisement

Topics

EU Horizon grants $4.7M to TC BioPharm for cancer study

10:20 EDT 4 Aug 2017 | SmartBrief

The European Union's Horizon 2020 has granted $4.7 million to TC BioPharm to advance the latter's gamma-delta T cell OmnImmun -More

Original Article: EU Horizon grants $4.7M to TC BioPharm for cancer study

NEXT ARTICLE

More From BioPortfolio on "EU Horizon grants $4.7M to TC BioPharm for cancer study"

Quick Search
Advertisement